{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Épanchement pleural malin : Questions médicales les plus fréquentes",
"headline": "Épanchement pleural malin : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Épanchement pleural malin : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-28",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Épanchement pleural malin"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs de la plèvre",
"url": "https://questionsmedicales.fr/mesh/D010997",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de la plèvre",
"code": {
"@type": "MedicalCode",
"code": "D010997",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.785.640"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Épanchement pleural malin",
"alternateName": "Pleural Effusion, Malignant",
"code": {
"@type": "MedicalCode",
"code": "D016066",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Najib M Rahman",
"url": "https://questionsmedicales.fr/author/Najib%20M%20Rahman",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, United Kingdom."
}
},
{
"@type": "Person",
"name": "Hans-Stefan Hofmann",
"url": "https://questionsmedicales.fr/author/Hans-Stefan%20Hofmann",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Michael Ried",
"url": "https://questionsmedicales.fr/author/Michael%20Ried",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Chang Ho Kim",
"url": "https://questionsmedicales.fr/author/Chang%20Ho%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea."
}
},
{
"@type": "Person",
"name": "Jae Kwang Lim",
"url": "https://questionsmedicales.fr/author/Jae%20Kwang%20Lim",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Korea."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies.",
"datePublished": "2023-02-13",
"url": "https://questionsmedicales.fr/article/36831535",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cancers15041193"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.",
"datePublished": "2023-02-09",
"url": "https://questionsmedicales.fr/article/36759870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13048-023-01106-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Classification of benign and malignant subtypes of breast cancer histopathology imaging using hybrid CNN-LSTM based transfer learning.",
"datePublished": "2023-01-30",
"url": "https://questionsmedicales.fr/article/36717788",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12880-023-00964-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Xiaoaiping improves the general state of rats with malignant ascites secondary to gastric cancer by blocking the TGF-β1 signaling pathway.",
"datePublished": "2023-01-15",
"url": "https://questionsmedicales.fr/article/36777819",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Coexistence of malignancy and tuberculosis: is it double disease or double hit related to COVID-19? - Experience from a tertiary care center.",
"datePublished": "2023-01-15",
"url": "https://questionsmedicales.fr/article/36815938",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012142"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs de la plèvre",
"item": "https://questionsmedicales.fr/mesh/D010997"
},
{
"@type": "ListItem",
"position": 5,
"name": "Épanchement pleural malin",
"item": "https://questionsmedicales.fr/mesh/D016066"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Épanchement pleural malin - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Épanchement pleural malin",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Épanchement pleural malin",
"description": "Comment diagnostiquer un épanchement pleural malin ?\nQuels tests sont utilisés pour analyser le liquide pleural ?\nQuels signes radiologiques indiquent un épanchement pleural ?\nQuelle est l'importance de la thoracocentèse ?\nPeut-on détecter un épanchement pleural par scanner ?",
"url": "https://questionsmedicales.fr/mesh/D016066?page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Épanchement pleural malin",
"description": "Quels sont les symptômes d'un épanchement pleural malin ?\nL'épanchement pleural peut-il causer de la fièvre ?\nComment l'épanchement pleural affecte-t-il la respiration ?\nY a-t-il des signes visibles d'épanchement pleural ?\nPeut-on avoir des symptômes sans épanchement visible ?",
"url": "https://questionsmedicales.fr/mesh/D016066?page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Épanchement pleural malin",
"description": "Comment prévenir l'épanchement pleural malin ?\nLes vaccinations peuvent-elles aider ?\nEst-il possible de prévenir les récidives ?\nLe mode de vie influence-t-il le risque ?\nLes soins palliatifs peuvent-ils prévenir l'épanchement ?",
"url": "https://questionsmedicales.fr/mesh/D016066?page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Épanchement pleural malin",
"description": "Quels traitements sont disponibles pour l'épanchement pleural malin ?\nQuand utilise-t-on un drain pleural ?\nLa chimiothérapie est-elle efficace pour l'épanchement malin ?\nQuels sont les effets secondaires des traitements ?\nPeut-on traiter l'épanchement pleural par radiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D016066?page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Épanchement pleural malin",
"description": "Quelles complications peuvent survenir avec un épanchement pleural malin ?\nL'épanchement pleural peut-il causer des douleurs chroniques ?\nComment l'épanchement pleural affecte-t-il la qualité de vie ?\nPeut-on développer une infection après un drainage ?\nQuelles sont les conséquences d'une fibrose pleurale ?",
"url": "https://questionsmedicales.fr/mesh/D016066?page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Épanchement pleural malin",
"description": "Quels sont les principaux facteurs de risque d'épanchement pleural malin ?\nL'âge influence-t-il le risque d'épanchement pleural ?\nLes maladies pulmonaires chroniques sont-elles un facteur de risque ?\nLe sexe joue-t-il un rôle dans le risque d'épanchement ?\nL'exposition professionnelle peut-elle augmenter le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016066?page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un épanchement pleural malin ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par échographie, thoracocentèse et analyse du liquide pleural."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour analyser le liquide pleural ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la cytologie, la culture et les marqueurs tumoraux."
}
},
{
"@type": "Question",
"name": "Quels signes radiologiques indiquent un épanchement pleural ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les radiographies montrent une opacité pleurale et l'échographie révèle la quantité de liquide."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la thoracocentèse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thoracocentèse permet de retirer le liquide et d'obtenir un échantillon pour analyse."
}
},
{
"@type": "Question",
"name": "Peut-on détecter un épanchement pleural par scanner ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le scanner thoracique est très efficace pour visualiser les épanchements pleuraux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un épanchement pleural malin ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent essoufflement, douleur thoracique et toux persistante."
}
},
{
"@type": "Question",
"name": "L'épanchement pleural peut-il causer de la fièvre ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une infection associée peut provoquer de la fièvre avec l'épanchement."
}
},
{
"@type": "Question",
"name": "Comment l'épanchement pleural affecte-t-il la respiration ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut réduire la capacité pulmonaire, entraînant une dyspnée et une fatigue."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes visibles d'épanchement pleural ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement du thorax ou une asymétrie peuvent être visibles à l'examen physique."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans épanchement visible ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent apparaître même avec un épanchement léger ou modéré."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'épanchement pleural malin ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par le dépistage précoce des cancers et un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins contre certaines infections pulmonaires peuvent réduire le risque."
}
},
{
"@type": "Question",
"name": "Est-il possible de prévenir les récidives ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et un traitement approprié des cancers peuvent aider à prévenir les récidives."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, sans tabac, peut réduire le risque de cancers et d'épanchements."
}
},
{
"@type": "Question",
"name": "Les soins palliatifs peuvent-ils prévenir l'épanchement ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins palliatifs visent à améliorer la qualité de vie et peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'épanchement pleural malin ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thoracocentèse, les drains pleuraux et la chimiothérapie."
}
},
{
"@type": "Question",
"name": "Quand utilise-t-on un drain pleural ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un drain est utilisé pour évacuer le liquide en cas d'épanchement important ou récurrent."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace pour l'épanchement malin ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut réduire la taille des tumeurs et diminuer l'épanchement."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fatigue, nausées et infections."
}
},
{
"@type": "Question",
"name": "Peut-on traiter l'épanchement pleural par radiothérapie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour réduire l'épanchement dans certains cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un épanchement pleural malin ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'infection, la fibrose pleurale et l'insuffisance respiratoire."
}
},
{
"@type": "Question",
"name": "L'épanchement pleural peut-il causer des douleurs chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs thoraciques persistantes peuvent survenir à cause de l'épanchement."
}
},
{
"@type": "Question",
"name": "Comment l'épanchement pleural affecte-t-il la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut entraîner une fatigue, une dyspnée et une limitation des activités quotidiennes."
}
},
{
"@type": "Question",
"name": "Peut-on développer une infection après un drainage ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque d'infection après une thoracocentèse ou un drainage pleural."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une fibrose pleurale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fibrose pleurale peut limiter l'expansion pulmonaire et aggraver la dyspnée."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'épanchement pleural malin ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de cancer, le tabagisme et l'exposition à des agents cancérigènes augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'épanchement pleural ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les personnes de plus de 65 ans."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires chroniques sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la BPCO augmentent le risque d'épanchement pleural."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le risque d'épanchement ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cancers liés à l'épanchement peuvent être plus fréquents chez un sexe."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle peut-elle augmenter le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à l'amiante ou à d'autres substances toxiques est un facteur de risque."
}
}
]
}
]
}
Cancer represents a major cause of death worldwide and is characterized by the uncontrolled proliferation of abnormal cells that escape immune regulation. It is now understood that cancer-associated f...
The mortality rate of ovarian cancer ranks first among three common gynecological malignant tumors due to insidious onset and lack of effective early diagnosis methods. Borderline epithelial ovarian t...
CA125, NLR and PLR increased steadily among benign, borderline and malignant EOTs and tended to be higher in advanced (stage III-IV) and lymph node metastasis MEOT groups than in early stage (stage I-...
The levels of CA125, NLR and PLR were closely related to the nature of EOTs and malignant progression of MEOTs. The combination of CA125, NLR and PLR was more accurate in identifying the nature of EOT...
Grading of cancer histopathology slides requires more pathologists and expert clinicians as well as it is time consuming to look manually into whole-slide images. Hence, an automated classification of...
To develop a hybrid model using the convolutional neural network (CNN) and the long short-term memory recurrent neural network (LSTM RNN) to classify four benign and four malignant breast cancer subty...
The proposed hybrid CNN-LSTM model was compared with the existing CNN models used for breast histopathological image classification such as VGG-16, ResNet50, and Inception models. All the models were ...
To conclude, the proposed transfer learning approach outperformed the state-of-the-art machine and deep learning models in classifying benign and malignant cancer subtypes. The proposed method is feas...
To investigate the effect of Xiaoaiping on the general state of rats with malignant ascites secondary to gastric cancer by blocking the transforming growth factor-β1 (TGF-β1) signaling pathway....
Fifty healthy Wistar rats were randomly divided into 5 groups, with 10 rats in each group. After successful modeling, 0.2 g/(20 g∙d), 0.4 g/(20 g∙d) and 0.8 g/(20 g∙d) of Xiaoaiping injections were ad...
PLT and WBC counts in the MG were lower than those in the CG. Ascites volume, tumor cell survival rate, and SF in the MG were higher than those in the LDG, MDG and HDG (...
Xiaoaiping could significantly reduce the ascites volume in rats with gastric cancer, inhibit the production of tumor cells in the abdominal cavity, and improve the general state of rats in a dose-dep...
Coexistent malignancy and tuberculosis (TB) are rarely encountered. Cancer patients are a highly vulnerable subgroup during this Covid crisis. Delayed treatment for malignancy because of COVID-19 pand...
The present study aimed to present the clinicopathologic profile of the patients with coexistent carcinoma and TB during the COVID-19 pandemic in a tertiary care center....
This was a retrospective study conducted during the COVID-19 pandemic between April 2020 to May 2021 in the Department of Pathology of our Institute. 11 patients with coexistent malignancy and caseous...
Eleven cases were reported with coexistent malignancy and tuberculosis, of which 8 were reported in 2021 and 3 cases were reported in 2020. Adenocarcinoma comprised 9 cases (81.8%) and the remaining 2...
In this covid pandemic, India being the 2...
To evaluate the early and late outcomes of continent and incontinent external urinary diversion in management of patients with refractory non-malignant lower urinary tract dysfunction (LUTD)....
The charts of patients with refractory non-malignant LUTD who underwent continent or incontinent external urinary diversion at University of Cincinnati hospitals in the period between March 2012 and D...
A total of 78 patients including 55 patients with neurogenic bladder (NGB) and 23 patients with non-neurogenic bladder (non-NGB) refractory non-malignant LUTD were included. Fifty-three patients under...
External urinary diversion can achieve a reasonable level of urological symptoms control in patients with refractory non-malignant LUTD, but with associated adverse outcomes. Although non-significantl...
Incidence of Malignant Melanoma has become the 5th in the UK. To date, the major anticancer therapeutics include cell therapy, immunotherapy, gene therapy and nanotechnology-based strategies. Recently...
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new, palliative approach for patients with peritoneal surface malignancies (PSMs). Its main goals are to control symptoms and ascites. For...
We performed a prospective registry study for patients with PSMs. Cisplatin (C) (7.5 mg/m...
Between November 2015 and June 2020, we recorded data from 108 patients and 230 scheduled procedures. Tumor burden, patient fitness, quality of life, operating time and in-hospital stay remained stabl...
PIPAC is effective in stabilizing PSMs and retaining quality of life in selected patients. Earlier abdominal surgeries and CRS with HIPEC should be considered when determining the indication for PIPAC...
NCT03100708 (April 2017)....
Although a substantial proportion of small soft tissue tumors are malignant, magnetic resonance imaging (MRI) features and demographic characteristics associated with these tumors have not been well d...
To investigate the MRI features and demographic characteristics associated with small (≤5 cm) malignant soft tissue tumors, and to identify independent predictors that allow differentiation of small b...
This retrospective study evaluated patients who underwent surgical excision of small soft tissue tumors of the extremities and superficial trunk, and preoperative contrast-enhanced MRI. Seven MRI find...
A total of 221 patients (102 men; mean age=45.6 ± 17.6 years) with 72 malignant and 149 benign tumors were included. In the univariate analysis, peritumoral edema (odds ratio [OR] = 3.854;...
Among several MRI and demographic features, the presence of peritumoral enhancement on MRI and patient age (≥46 years) were independent predictors of malignancy in small soft tissue tumors....
Chronic kidney disease (CKD) is associated with gut microbiome dysbiosis, but the role of intestinal flora in CKD treatment remains to be elucidated. Fecal microbiota transplantation (FMT) can be util...